Scott Gottlieb appointed to the FDA’s top role
May 10, 2017Manufacturing and Production, Research and Development, Sales and Marketing FDA, Scott Gottlieb, Trump
After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …
Kymab instates first Chief Medical Officer
May 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab
Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …
Duchenne drug poised to cost $35,000 but with major catch
May 9, 2017Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, PTC Therapeutics, marathon
For those that have not followed the story, Emflaza was successfully taken through the FDA regulatory process by Marathon as …
University of Oxford gains access to biomarker profiling technology
May 9, 2017Manufacturing and Production, Research and Development Nightingale health, University of Oxford
The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will …
73% of India’s doctors oppose prescribing generics over branded versions
May 9, 2017Manufacturing and Production, Sales and Marketing India, generics
Following a recent push by Indian Prime Minister Narendra Modi for doctors in the country to prescribe generic drugs over …
The Manufacturer’s Organisation calls for robust industrial strategy with new manifesto
May 9, 2017Manufacturing and Production EFF, The Manufacter's Organisaion
With the 8 June general election only a month away, the EEF – The Manufacturer’s Organisation – has become the …
£6 million statin study to determine potential therapeutic use in MS
May 9, 2017Manufacturing and Production, Research and Development multiple sclerosis, statins
A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …
Pricing Consultant Job Profile and Description
May 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
About Global Pricing Innovations (GPI)
Head of Product Innovation Job Profile and Description
May 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
About Global Pricing Innovations (GPI)
Patient reported outcomes: Putting the patient first
May 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
With clinical practice marching towards a more precision-oriented methodology, assessment of treatment efficacy is undergoing a transformation. Matt Fellows explores the …
Teva and Active Biotech hit by Phase 3 drug failure
May 8, 2017Research and Development, Sales and Marketing Active Biotech, Teva
Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …
Weight loss pill treatment rejected by NICE
May 8, 2017Medical Communications, Sales and Marketing NICE, orexigen
NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …
Board battle scuppers Seattle Genetics’ $2 billion licensing deal
May 8, 2017Sales and Marketing Immunomedics, Seattle Genetics, venBio
In another example of the influence that activist investors can have on the direction of a business, the potentially $2 …
NHS staff feeling the pay squeeze, reports NHS Providers
May 8, 2017Medical Communications, Sales and Marketing NHS, NHS Providers
NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …
FDA approves first new treatment for ALS in two decades
May 8, 2017Sales and Marketing MLS, Mitsubishi Tanabe Pharma America, Radicava
The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …
Top Ten most popular articles on Pharmafile.com this week
May 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …
Pfizer offers breast cancer drug for free following NICE rejection
May 5, 2017Medical Communications, Sales and Marketing NICE, Pfizer
Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …
Regulus CEO heads to exit as company struggles with FDA hold
May 5, 2017Medical Communications, Research and Development Regulus, hepatitis C
Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …
J&J chalks up another defeat in $110 million talc-cancer case
May 5, 2017Medical Communications Johnson & Johnson, baby powder
Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …
GSK boosts Benlysta production with $139 million investment
May 5, 2017Manufacturing and Production, Medical Communications GSK
GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
